Literature DB >> 15962328

Transforming growth factor beta can mediate apoptosis via the expression of TRAIL in human hepatoma cells.

Kerstin Herzer1, Tom M Ganten, Henning Schulze-Bergkamen, Anne Grosse-Wilde, Ronald Koschny, Peter H Krammer, Henning Walczak.   

Abstract

Transforming growth factor beta (TGF-beta) has been shown to induce apoptotic cell death in normal and transformed hepatocytes. However, the exact mechanism through which TGF-beta induces cell death is still unknown. We examined a potential role of various death receptor/ligand systems in TGF-beta-induced apoptosis and identified the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) as a mediator of TGF-beta-induced apoptosis in hepatoma cells. TGF-beta-induced apoptosis is significantly impaired upon blockage of TRAIL. We show that TRAIL is upregulated in hepatoma cells upon treatment with TGF-beta, whereas TRAIL receptor levels remain unchanged. In conclusion, our results provide evidence that the TRAIL system is critically involved in TGF-beta-induced cell death in liver pathology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15962328     DOI: 10.1002/hep.20757

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

Review 1.  Following the TRAIL to apoptosis.

Authors:  Bharti R Chaudhari; Richard F Murphy; Devendra K Agrawal
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 2.  Coinfection with HIV-1 and HCV--a one-two punch.

Authors:  Arthur Y Kim; Raymond T Chung
Journal:  Gastroenterology       Date:  2009-06-21       Impact factor: 22.682

3.  TGF-β1 regulates cell fate during epithelial-mesenchymal transition by upregulating survivin.

Authors:  J Lee; J-H Choi; C-K Joo
Journal:  Cell Death Dis       Date:  2013-07-04       Impact factor: 8.469

4.  A -1573T>C SNP within the human TRAIL promoter determines TRAIL expression and HCC tumor progression.

Authors:  Katja Piras-Straub; Khaleda Khairzada; Peri Kocabayoglu; Andreas Paul; Guido Gerken; Kerstin Herzer
Journal:  Cancer Med       Date:  2016-08-31       Impact factor: 4.452

5.  Deficiency of the promyelocytic leukemia protein fosters hepatitis C-associated hepatocarcinogenesis in mice.

Authors:  Kerstin Herzer; Anna Carbow; Svenja Sydor; Jan-Peter Sowa; Stefan Biesterfeld; Thomas-Georg Hofmann; Peter-Robert Galle; Guido Gerken; Ali Canbay
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

6.  An Atypical System for Studying Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.

Authors:  Dhiviya Vedagiri; Hiren Vasantrai Lashkari; Abubakar Siddiq Mangani; Jerald Mahesh Kumar; Jedy Jose; Avinash Raj Thatipalli; Krishnan Harinivas Harshan
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

7.  PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation.

Authors:  Valeria Iansante; Pui Man Choy; Sze Wai Fung; Ying Liu; Jian-Guo Chai; Julian Dyson; Alberto Del Rio; Clive D'Santos; Roger Williams; Shilpa Chokshi; Robert A Anders; Concetta Bubici; Salvatore Papa
Journal:  Nat Commun       Date:  2015-08-10       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.